Activated Wnt signaling have been demonstrated to be associated with acquired tamoxifen resistance, and maintain the stem cell-like properties of ER + breast cancer (Loh et al., 2013; Ham et al., 2022). This evidence concerns the gene ESR1 and breast carcinoma.